Mursla Bio

Mursla Bio

First-in-class ANALYSIS of organ-specific extracellular vesicles from blood AI Precision Medicine and Diagnostics EvoLiver™ EvoLiver™ EvoLiver™ is the flagship blood test in our hepatology-led product portfolio, built on Mursla Bio's proprietary AI Precision Medicine Platform. EvoLiver™ is designed to detect liver cancer early in high risk populations with irreversible liver scarring (cirrhosis), when clinical

Private Company

Total funding raised: $2.5M

About

First-in-class ANALYSIS of organ-specific extracellular vesicles from blood AI Precision Medicine and Diagnostics EvoLiver™ EvoLiver™ EvoLiver™ is the flagship blood test in our hepatology-led product portfolio, built on Mursla Bio's proprietary AI Precision Medicine Platform. EvoLiver™ is designed to detect liver cancer early in high risk populations with irreversible liver scarring (cirrhosis), when clinical

Diagnostics

Funding History

1
Total raised:$2.5M
Seed$2.5M